Entera Bio Ltd. Quarterly Revenues in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Entera Bio Ltd. quarterly/annual Revenues history and growth rate from Q1 2021 to Q3 2024.
  • Entera Bio Ltd. Revenues for the quarter ending September 30, 2024 was $42K.
  • Entera Bio Ltd. annual Revenues for 2023 was $0.000, a 100% decline from 2022.
  • Entera Bio Ltd. annual Revenues for 2022 was $134K, a 76.5% decline from 2021.
  • Entera Bio Ltd. annual Revenues for 2021 was $571K, a 56.4% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $42K +$42K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $57K +$57K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q4 2023 $0 $0 -$14K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $14K $0 -$8K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $22K $0 -$44K -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $66K $0 -$68K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $134K $14K -$151K -91.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $285K $8K -$132K -94.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $417K $44K -$65K -59.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $482K $68K -$89K -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $571K $165K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $140K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $109K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $157K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.